USPTO serial 77259296
COSMO
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- EULIN, INGRID C
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with COSMO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joerg-Uwe Szipl
JOERG-UWE SZIPL GRIFFIN & SZIPL, PC2300 9TH ST S STE PH-1ARLINGTON, VA 22204-2387UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, veterinary and nutraceutical preparations, namely, tablets, capsules, sugar-coated pills, granules, powders, foams, pellets, solutions, emulsions, creams, ointment, gels, plasters for use in gastrointestinal proctology and gastrointestinal located and related infections in gastroenterology, proctology, and anti-infective field; pharmaceuticals, veterinary, and nutraceutical preparations for treatment of motility control; suppositories; enema preparations; anti-inflammatory; anti-acids; anti-parasitic, namely, parasiticides; pharmaceutical, veterinary and nutraceutical preparation for use in treating flatulence, namely, anti-flatulence tablets, capsules, sugar-coated pills, granules, powders, foams, pellets, solutions, emulsions, creams, ointment, gels and plasters; cosmetic products for medical use, namely, creams, liquid, gel, foam, emulsion, suspension and powder dermatological pharmaceutical products for use in treating burns and as a disinfectant | ACTIVE | — |
| 035 | Preparation of documents for business agendas in the field of pharmacy services, namely, data processing services in the field of pharmacy and medicine; compilation of business statistics related to the biostatistics field; online, mail order and telephone retail store featuring pharmacy and hospital; retail store featuring pharmacy and hospital; business management for pharmacies; advertising services to promote drug prescriptions; providing business information about pharmaceutical market share and pharmaceutical product trends, development and research projects; development of marketing strategies and concepts for pharmaceutical products, namely, tablets, capsules, sugar-coated pills, granules, powders, suppositories, enemas, foams, pellets, solutions, suspensions, emulsions, creams, ointments, gels, plasters for use in gastroenterology, proctocology, anti-flatulence fields; commercial administration of the licensing of goods and services of others; marketing consulting related to sales and volume data, prescription maker and numbers, general market trends, information regarding certain products and competitors, pharmaceutical, veterinary and nutraceutical preparations | ACTIVE | — |
| 042 | Medical research consisting of compilation and analysis of biostatistics; medical research in the form of pharmacovigilance in order to collect and process data on undesired and unexpected effects of medicines brought into the market; pharmaceutical research services related to the study, design, and development of new pharmaceutical, veterinary and nutraceutical preparations; chemical analysis; biological and bacteriological research; laboratory research in the field of medical and pharmaceutical sciences; medical and pharmaceutical research; research and development of new products intended for health; product safety testing related to blood levels of drugs up to their first administration to humans in the first phase of clinical trials; consumer product safety testing as related to preparation, organization and monitoring of different phases of clinical studies; medical research consisting of conducting epidemiological studies, clinical biochemistry and pharmacokinetic quality management in the field of clinical evaluation of drugs | ACTIVE | — |
| 045 | Licensing intellectual property related to pharmaceutical specialties, namely, cosmetic, nutraceuticals and dietetic supplements, veterinary and nutraceutical preparations in the form of tablets, capsules, sugar-coated pills, granules, powders, suppositories, enemas, foams, pellets, solutions, suspensions, emulsions, ointments, gels, and plasters for use in gastroenterology, proctology, and the anti-infective field, motility control, the anti-inflammatory field, anti-acid, anti-parasitic, and anti-flatulence fields; legal licensing consultation in connection with pharmaceutical, veterinary and nutraceutical preparations, namely, tablets, capsules, sugar-coated pills, granules, powders, suppositories, enemas, foams, pellets, solutions, suspensions, emulsions, creams, ointments, gels, plasters for use in gastroenterology, proctology, anti-infective field, motility control, anti-inflammatory field, anti-acid, anti-parasitic, and anti-flatulence field | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cosmo Pharmaceuticals SPA
- Other trademarks owned by Cosmo Pharmaceuticals SPA
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named COSMO
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 12, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 12, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 11, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 9, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 9, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 1, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 1, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 9, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 9, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 9, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 24, 2008 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jun 30, 2008 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 10, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 21, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| May 2, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 2, 2008 | ALIE | ASSIGNED TO LIE | — |
| May 2, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 1, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 1, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 1, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 28, 2007 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 24, 2007 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Aug 23, 2007 | NWAP | NEW APPLICATION ENTERED | — |